Peter Korsten

TL;DR: The European Respiratory Society Task Force (TF) as discussed by the authors developed recommendations based on the GRADE (Grading of Recommendations, Assessment, Development and Evaluations) methodology.

TL;DR: The authors appraise the study generating this interest and highlight the potential consequences of rapid dissemination of overinterpreted data, particularly for people with conditions for which hydroxychloroquine has demonstrated benefits in preventing organ damage and life-threatening disease flares.

TL;DR: The molecular mechanisms involved in the pathogenesis of AD and InsRes are reviewed and the function of FoxO proteins in these processes are discussed, suggesting they may provide a potential molecular target for the treatment of both InsRes and AD.

TL;DR: How TCZ may be beneficial in the treatment of other autoimmune diseases, spinal disease, cardiovascular disease, organ transplantation, and malignancies where elevated levels of IL-6 may play a role in the pathogenesis of these diseases is discussed.

TL;DR: The intent is to encourage a multidisciplinary, translational approach to meet the challenges and difficulties in understanding and treating sarcoidosis.